Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 67: 1463-1471, 1989;
8750-7587/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreil, E.
Right arrow Articles by Zapol, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreil, E.
Right arrow Articles by Zapol, W. M.

Journal of Applied Physiology, Vol 67, Issue 4 1463-1471, Copyright © 1989 by American Physiological Society

ARTICLES

Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions

E. Kreil, G. Montalescot, E. Greene, C. Fitzgibbon, D. Robinson, D. Chenoweth and W. M. Zapol
Department of Anesthesia, Massachusetts General Hospital, Boston 02114.

Rapid protamine reversal of heparin anticoagulation in awake sheep caused, after 1 min, a approximately 15-fold increase of arterial plasma thromboxane B2 (TxB2) levels, a 4-fold rise of pulmonary vascular resistance (PVR), a 2-fold rise of pulmonary arterial pressure, and after 3 min, a 2-fold rise of ovine arterial plasma complement C3a levels (P less than 0.05). Infusion of nafamstat mesilate (FUT-175), a protease and complement pathway inhibitor, before protamine reduced these increases by approximately 60-90% (P less than 0.05). FUT-175 did not modify heparin + protamine-induced leukopenia, suggesting that FUT-175 incompletely blocked C5a production. We also learned that infusing protamine first and heparin 5 min later did not increase either plasma C3a or TxB2 levels or PVR while the activated clotting time increased only minimally. Thus, in awake sheep, the sequence of heparin and protamine infusion influences complement activation and pulmonary vasoconstriction. FUT-175 pretreatment reduces thromboxane release and pulmonary vasoconstriction probably by limiting complement activation.


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
S. C. Makrides
Therapeutic Inhibition of the Complement System
Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Habazettl, V. Martinek, B. Vollmar, and P. Conzen
ENHANCEMENT OF THE LEUKOCYTE-ENDOTHELIAL CELL INTERACTION IN COLLECTING VENULES OF SKELETAL MUSCLE BY PROTAMINE
J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 784 - 791.
[Abstract] [Full Text]

Home page
 PerfusionHome page
A. Belboul and N. Al-Khaja
The effect of protamine on the epicardial microflow and the graft flow in open-heart surgery
Perfusion, March 1, 1997; 12(2): 99 - 106.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online